// App-Quantinova.ai

e16074 : Array-comparative genomic hybridization to predict resistance to VEGF-targeted therapies in patients with metastatic clear cell renal cell carcinoma.

Researchers

Presenter

  • Solene-Florence Kammerer-Jacquet

Principal Investigators

  • Frederic Dugay

  • Laurence Cluzeau

  • Angelique Brunot

  • Julien Dagher

  • Benoit Peyronnet

  • Romain Mathieu

  • Gregory Verhoest

  • Karim Bensalah

  • Brigitte Laguerre

  • Pierre Kerbrat

  • Frantz Dupuis

  • Jean-Christophe Bernard

  • Mokrane Yacoub

  • Alain Ravaud

  • Nathalie Rioux-Leclercq

  • Marc-Antoine Belaud-Rotureau

Medical Centers

  • Service d'Anatomie Pathologique CHU Pontchaillou, Rennes, France

  • Service de Cytogenetique CHU Pontchaillou, Rennes, France

  • Service de Cytogenetique CHU Pontchaillou, Rennes, France

  • Comprehensive Cancer Center Eugene Marquis, Rennes, France

  • University Hospital Pontchaillou, Rennes, France

  • Service d'Urologie, CHU Pontchaillou, Rennes, France

  • Service d'Urologie, CHU Pontchaillou, Rennes, France

  • Department of Urology University Hospital Pontchaillou, Rennes, France

  • Centre Eugene-Marquis, Rennes, France

  • Medical Oncology Eugene Marquis Comprehensive Cancer Center, Rennes, France

  • Department of Pathology Bordeaux University hospital, Bordeaux, France

  • Bordeaux Hospital University Center, Bordeaux, France

  • Hopital Saint-Andre, CHU de Bordeaux, Bordeaux, France

  • Department of Pathology Pontchaillou University Hospital, Rennes, France

  • Service de Cytogenetique CHU Rennes, Rennes, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final